October 01, 2011 Archives - Clinical Advisor

Print Issue: October 01, 2011

New option for those starting HIV therapy

New option for those starting HIV therapy

Rilpivirine, a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor of HIV-1, approved for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve adult patients.

Next post in Clinical Pearls